2023

1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

   Science advances, Vol. 9, Núm. 33, pp. eadf6692

2. Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies

   EMBO Molecular Medicine, Vol. 15, Núm. 11

3. Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

   Molecular Therapy - Nucleic Acids, Vol. 33, pp. 668-682

4. Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic

   OncoImmunology, Vol. 12, Núm. 1